Inpatient Management Techniques for Gastrointestinal & Liver Function

Discover effective inpatient management techniques to optimize care and improve patient prognosis in gastrointestinal and liver function.

Abstract

I am Dr. Alex Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST. In this educational post, I guide you through a comprehensive, easy-to-follow journey across the major topics in gastroenterology and hepatology that I manage daily in our multidisciplinary clinic in El Paso, Texas. Drawing on modern, evidence-based research and the latest findings from leading investigators, I explain how we diagnose and treat upper and lower gastrointestinal bleeding, peptic ulcer disease and NSAID-related injury, pill esophagitis, inflammatory bowel disease flares, acute pancreatitis, cholangitis versus choledocholithiasis, dysphagia, mesenteric ischemia, fecal impaction, restrictive transfusion strategies, iron deficiency anemia, and complex liver conditions including acute liver failure, alcohol-associated hepatitis, decompensated cirrhosis, portal hypertension syndromes, hepatorenal syndrome, ascites, hepatic encephalopathy, portal vein thrombosis, and the interpretation of abnormal liver enzymes. I also show how our integrated model at Injury Medical Clinic PA (Mission Plaza Injury Medical Clinic) combines internal medicine oversight by Dr. Maria Guadalupe Cardenas, MD (Board Certified in Internal Medicine; NPI #1164426749; Texas MD License #J2933) with my chiropractic and functional medicine services, personal injury care, and rehabilitation to deliver safe, whole-person care. Throughout, I highlight how integrative chiropractic care fits into these pathways, supporting autonomic balance, musculoskeletal optimization, breathing mechanics, and functional recovery, with clinical observations I’ve documented at pushasrx.com and on my LinkedIn profile. Citations follow APA-7 style with hyperlinked references.

Our Multidisciplinary Care Model in El Paso: Internal Medicine Oversight With Chiropractic Integration

At Injury Medical Clinic PA (Mission Plaza Injury Medical Clinic), our care model reflects a modern, integrative approach in which a medical doctor provides medical direction alongside a chiropractor. I practice as a Doctor of Chiropractic (DC), Advanced Practice Registered Nurse (APRN), Family Nurse Practitioner (FNP-BC), and certified functional medicine practitioner (CFMP, IFMCP, ATN, CCST). Our Medical Director and Collaborative Physician is Dr. Maria Guadalupe Cardenas, MD, a Board-Certified Internist with more than 40 years of experience (NPI #1164426749; Texas MD License #J2933). Together, we deliver coordinated, evidence-based care across gastrointestinal and hepatic conditions, personal injuries, and complex chronic disease.

• Medical oversight (Dr. Cardenas): Diagnostic stewardship, pharmacologic management, inpatient/outpatient coordination, hepatology protocols, infection screening, and transplant referral pathways.
• Chiropractic care (Dr. Jimenez): Gentle, patient-specific manual therapies, neuromuscular re-education, breathing mechanics training, autonomic modulation, and structural rehabilitation to optimize function and reduce pain.
• Functional medicine: Nutrition optimization, micronutrient repletion, gut-liver axis support, personalized lifestyle interventions, and precision supplementation when indicated.
• Rehabilitation and personal injury care: Graded movement plans, gait and core stabilization, orthostasis management, and recovery support aligned with medical safety.
• Care coordination: Lab timing optimization, imaging and procedural logistics, albumin replacement planning, and follow-up scheduling aligned with prognosis and resources.

This integrated framework allows us to keep medical safety central while addressing biomechanics, autonomic tone, nutrition, and behavior, domains that often determine real-world outcomes. My clinical observations, published on pushasrx.com and shared on LinkedIn, consistently show improved patient adherence, faster recovery, and better quality of life when pain is reduced, sleep normalizes, and nutrition becomes manageable.

Understanding Upper GI Bleeding: Clinical Nuances, Risk Stratification, and When to Scope

When a patient presents with signs of a gastrointestinal (GI) bleed, urgency and accuracy matter. We distinguish upper from lower sources and apply the latest risk-stratification tools to guide action.

• Melena (black, tarry stools): Often indicates an upper GI bleed proximal to the ligament of Treitz, but elderly patients with slow motility can develop melena from right-sided colonic or small bowel bleeding if blood is digested over time. Melena can persist for up to 5 days after bleeding has stopped; we distinguish active from residual bleeding based on hemodynamic stability, hemoglobin trends, and symptoms (Laine et al., 2021).
• Hematochezia (bright red blood per rectum): Typically lower GI, but brisk, high-volume upper GI bleeding can present with hematochezia and hemodynamic instability requiring ICU-level support.
• Common causes: Peptic ulcer disease (PUD) from H. pylori or NSAIDs, esophageal varices and portal gastropathy, malignancy, marginal ulcers post-Roux-en-Y gastric bypass, and Mallory-Weiss tears (Laine et al., 2021).

We use tools such as the Glasgow-Blatchford Score to stratify risk and decide on urgent endoscopy versus outpatient evaluation (Laine et al., 2021). In selected elderly patients with melena and low suspicion for an upper source, we prep for colonoscopy concurrently or first, because I have seen numerous cases where an initial EGD is unrevealing, and the culprit lies in the right colon.

• Clinical reasoning: If hemoglobin is profoundly low (e.g., 4 g/dL) but EGD shows only mild gastritis, we investigate lower sources next; otherwise, we proceed to CT angiography or push enteroscopy for obscure bleeding.

Why Integrative Chiropractic Care Matters Here

• Autonomic modulation: Gentle adjustments help reduce sympathetic overdrive during acute illness, supporting gut perfusion and motility in recovery.
• Breathing mechanics and posture: Thoracic mobility and diaphragmatic training can enhance oxygenation and reduce strain during convalescence.

Uncovering Hidden Ulcer Etiologies: NSAID Use and Pill-Induced Esophagitis

A major pitfall in PUD management is missing the root cause.

• Surreptitious NSAID use: Patients may not recognize ibuprofen, naproxen, aleve, meloxicam, BC Powder, or Alka-Seltzer as NSAIDs. We ask specifically and often involve caregivers to inspect medicine cabinets. Eliminating NSAID exposure prevents recurrent bleeding.
• Pill esophagitis from doxycycline: Ulceration can occur within 1–2 days due to concentrated mucosal injury if the capsule lodges in the esophagus. We teach patients to take at least a full glass of water and remain upright for 30 minutes.

Integrative Chiropractic Alternatives for Pain

Simply telling a patient with osteoarthritis or migraines to switch to acetaminophen is often inadequate. My team offers non-pharmacologic strategies that can reduce NSAID reliance:

• Osteoarthritis: Chiropractic adjustments, mobilization, targeted rehab, anti-inflammatory diets, and botanicals such as curcumin and boswellia can reduce pain and swelling.
• Migraines: Many have cervicogenic contributions; spinal manipulation, soft tissue therapy, and corrective exercises relieve upper cervical and thoracic dysfunction, lowering frequency and intensity.

By effectively relieving pain, we protect the GI mucosa while improving quality of life.

Proton Pump Inhibitor Therapy: Balancing Risks and Protecting High-Risk Patients

There is a recent trend to deprescribe proton pump inhibitors (PPIs). While long-term risks warrant consideration, we must not overlook the severe consequences of undertreating high-risk patients.

• Indefinite PPI therapy may be indicated for large hiatal hernias with Cameron ulcers, significant non-surgical ulcers, or those on long-term anticoagulation with a history of peptic ulcers (Laine et al., 2021).
• Pylori eradication with quadruple therapy and a test of cure is essential to prevent recurrence (Laine et al., 2021).

In functional medicine, we mitigate PPI downsides through nutrient repletion (B12, magnesium, calcium), microbiome support, and diet strategies.

Lower GI Bleeding: Painful Versus Painless, and Colonoscopy Timing

Distinguishing painless from painful lower GI bleeding directs the differential:

• Painless: Diverticulosis, angiodysplasias, and hemorrhoids.
• Painful: Ischemic colitis, inflammatory bowel disease (IBD), infection, or malignancy (Strate & Gralnek, 2016).

A landmark randomized trial demonstrated no significant difference in outcomes between colonoscopy performed within 24 hours and 24–96 hours, allowing time to optimize bowel prep for higher diagnostic yield. It reduced the risk of anesthesia (Oakland et al., 2020).

Chiropractic Support for Lower GI Bleeds

• Autonomic balance: Gentle adjustments can dampen sympathetic activation triggered by cramping and pain, improving motility and comfort.
• Recovery mechanics: Postural training and core stabilization facilitate safe activity during and after hospitalization.

Managing Anticoagulation During GI Bleeding: Precision and Safety

For patients on anticoagulants (e.g., apixaban for atrial fibrillation) presenting with a GI bleed, we balance bleeding against thrombotic risk:

• Assess the indication: Stroke risk in atrial fibrillation differs from aspirin for primary prevention.
• Consider half-life: DOAC effects wane over 2–3 days with normal renal function.
• Heparin bridge: Short half-life heparin allows rapid titration and reversal if re-bleeding occurs, “pressure-testing” stability before resuming oral anticoagulation (Jairath & Barkun, 2014).

My clinical experience shows that restarting anticoagulation in a monitored setting reduces adverse events. For selected patients with atrial fibrillation at high bleeding risk, we discuss Watchman device options with cardiology to reduce the long-term anticoagulation burden (Reus et al., 2018, for AUD treatment interactions and broader safety considerations).

Root Causes of *GUT DYSFUNCTION*- Video

Case Integration: John’s Upper GI Bleed With Hiatal Hernia and Cameron Ulcers

A 72-year-old man with melena, dizziness, atrial fibrillation on apixaban, chronic kidney disease, and prior stent presents with hemoglobin 6.8 g/dL. EGD reveals a small gastric ulcer and large hiatal hernia with Cameron ulcers, fully explaining severe anemia.

• Immediate management: Stabilization, transfusion as indicated, holding apixaban, and initiating high-dose IV PPI.
• Long-term plan: Lifelong PPI due to non-surgical large hiatal hernia; test and treat pylori.
• Resuming anticoagulation: Once hemoglobin is stable 48–72 hours post-procedure, restart apixaban or consider a heparin bridge in a monitored setting.
• Chiropractic and rehab: Thoracic adjustments, breathing and core exercises to reduce mechanical stress on the hernia and support recovery.

This integrated approach addresses the bleed, protects from stroke, and supports functional recovery.

Acute Pancreatitis: Fluids, Multimodal Pain Control, and Early Nutrition

Acute pancreatitis requires decisive and physiologically informed management (Lankisch, Apte, & Banks, 2015):

• Aggressive IV hydration with Lactated Ringer’s supports pancreatic perfusion and reduces the risk of necrosis.
• Multimodal analgesia: Short-course NSAIDs (e.g., ketorolac), scheduled acetaminophen, opioids for breakthrough, and neuropathic agents (gabapentin or pregabalin) reduce opioid burden.
• Early enteral nutrition: Starting oral intake early, as tolerated, maintains gut integrity, reduces bacterial translocation, and lowers the risk of infection.
• Complications: Avoid prophylactic antibiotics; wait ≥4 weeks for pseudocyst wall maturation before drainage.

Chiropractic care helps address visceral-somatic reflex patterns, soft-tissue mobilization, and gentle adjustments to reduce muscular guarding and enhance breathing, thereby supporting pain control and function.

Cholangitis Versus Choledocholithiasis: Recognizing Sepsis and Timing ERCP

Cholangitis presents with fever, chills, and systemic toxicity; it is an endoscopic emergency needing ERCP within 24 hours to decompress the infected duct (Lee, 2021). In elderly patients, subtle signs such as diaphoresis or a “feeling feverish” may substitute for overt fever. Choledocholithiasis may also require ERCP, though urgency differs; clearing the duct before cholecystectomy reduces surgical complications.

Mesenteric Ischemia and Ischemic Colitis: Hypoperfusion Recognition

Elderly patients with hypotension (e.g., during dialysis) and pre-existing stenosis are vulnerable to mesenteric ischemia. CT may show bowel wall thickening in watershed regions; colonoscopy reveals dusky, ulcerated tissue (Bala et al., 2017). We consider anticoagulation if major vascular occlusion is present and consult vascular surgery for stenting; severe cases require surgical resection. Post-injury, gentle laxatives such as polyethylene glycol help avoid pressure-related worsening.

Fecal Impaction: Location-Specific Treatment and Digital Disimpaction

Effective management starts with imaging review to localize impaction. Right-sided stool requires oral agents; rectal impaction demands digital disimpaction before enemas or suppositories (Obokhare, 2012). We then initiate a maintenance bowel regimen and educate staff about overflow diarrhea so laxatives aren’t inappropriately held.

Dysphagia: Oropharyngeal Versus Esophageal Patterns

We distinguish oropharyngeal dysphagia (difficulty initiating swallow) from esophageal dysphagia (food sticks seconds after swallowing) (Khan & Vaezi, 2012):

• Solids-only dysphagia: Mechanical obstruction (stricture, ring) requiring EGD and dilation.
• Solids and liquids: Motility disorder.
• Odynophagia: Consider infection or pill-induced esophagitis.

Chiropractic contributions include cervical and thoracic mobility work and soft-tissue techniques that may indirectly improve swallowing comfort by reducing musculoskeletal tension and optimizing posture.

Diarrhea, C. difficile, and Antibiotic Prudence

I always clarify what patients mean by “diarrhea.” Imaging often reveals severe constipation or impaction in those reporting “frequent stools.” We avoid empiric antibiotics, especially in suspected STEC, due to the risk of hemolytic uremic syndrome. We strongly consider community-associated C. difficile, which increasingly occurs without recent antibiotic exposure. For initial episodes, fidaxomicin reduces recurrence rates compared with vancomycin; for recurrent disease, microbiota-based therapies such as Vowst and Rebyota are effective (Mishra & Khanna, 2021).

Inflammatory Bowel Disease Flares: Steroid Limits, Thromboprophylaxis, and Long-Term Planning

IBD inpatients often face small bowel obstruction, abscess, fistulae, and very high venous thromboembolism (VTE) risk (Strate & Gralnek, 2016):

• Rule out infection (especially C. difficile, CMV).
• Steroid dosing: Avoid doses above 60 mg/day of prednisone-equivalent; many experts cap at 40 mg/day to reduce complications.
• Thromboprophylaxis: Heparin is preferred for short half-life and reversibility; rectal bleeding rarely worsens meaningfully.
• Long-term planning: Optimize biologic therapy (e.g., infliximab), consider immunomodulators, assess drug antibodies, and escalate promptly if steroids fail (Siegel, 2023).

Chiropractic care assists by lowering sympathetic tone, improving pain control, and supporting graded movement that reduces deconditioning.

Iron Deficiency Anemia and Restrictive Transfusion Strategy

Iron deficiency is an alarm sign for occult GI bleeding. Ferrous sulfate with vitamin C can be effective, but many patients tolerate oral iron poorly; I use IV iron liberally in the hospital to safely and quickly replete stores. We employ restrictive transfusion strategies (typical thresholds around 7 g/dL), giving one unit at a time and reassessing, with higher thresholds in select cardiac populations (Carson et al., 2016). In cirrhosis, over-transfusion can raise portal pressure and worsen variceal bleeding (Villanueva et al., 2013).

Acute Liver Failure: Encephalopathy, Coagulopathy, and Early NAC

Acute liver failure is defined by acute hepatocellular injury, coagulopathy, and hepatic encephalopathy; we monitor mental status vigilantly and engage transplant centers early (Bernal & Wendon, 2010). We consider N-acetylcysteine (NAC) even in non-acetaminophen causes due to its glutathione-replenishing and microcirculatory benefits (Polson & Lee, 2005; Lee et al., 2012). We observe for pruritus, rash, and rare anaphylaxis.

Chiropractic integration focuses on thoracic mobility and diaphragmatic training to improve oxygenation and venous return, stabilize autonomic responses, and reduce agitation associated with encephalopathy.

Alcohol-Associated Hepatitis: Severity Scoring, Infection Screening, NAC, and Steroid Caution

We assess severity via MELD/MELD 3.0 and sometimes GAHS, then aggressively screen for infection (blood/urine cultures, chest X-ray, paracentesis if ascites) because infection is common and often silent (Kim et al., 2021; Forrest et al., 2005). Steroids may offer short-term survival benefits but raise infection risks; I am selective (Mathurin & Lucey, 2012). NAC is increasingly considered to mitigate oxidative stress (Singal et al., 2018). We use phosphatidylethanol (PEth) to quantify alcohol exposure when needed (Stewart et al., 2014). There is no universal six-month abstinence rule—severe first episodes may warrant early transplant evaluation (Im et al., 2019). We treat alcohol use disorder using medication-assisted therapy (acamprosate, naltrexone where appropriate, and gabapentin adjuncts) plus counseling (Reus et al., 2018).

Chiropractic and rehab reduce pain, support sleep, and allow graded activity, improving neuroendocrine balance and reducing relapse risk, as I’ve observed in real-world practice on pushasrx.com and LinkedIn.

Decompensated Cirrhosis: Ascites, Varices, Encephalopathy, and HCC Screening

We identify the cause of cirrhosis (AAH, MASLD, hepatitis C), treat the underlying disease, and screen for hepatocellular carcinoma (HCC) every six months with ultrasound ± AFP (EASL, 2018). Common triggers of decompensation include infection, drug-induced liver injury, portal vein thrombosis, HCC, and alcohol recidivism.

Chiropractic strategies target postural stability, core function, and reduced abdominal wall strain to ease ascites-related discomfort, lower fall risk, and reduce the need for sedatives that can worsen encephalopathy.

Portal Hypertension Pulmonary Syndromes: Hepatopulmonary Syndrome and Portopulmonary Hypertension

We recognize platypnea and orthodeoxia—worsening oxygenation while upright—as signs of hepatopulmonary syndrome (HPS) and confirm with contrast (“bubble”) echocardiography; the main therapy is liver transplantation with oxygen support (Krowka et al., 2018). Chiropractic breathing mechanics and thoracic mobility can improve diaphragmatic excursion while we coordinate transplant evaluation.

Hepatorenal Syndrome–AKI: Vasoconstrictors and Albumin

In HRS-AKI, after ruling out parenchymal kidney disease and obstruction, we treat with terlipressin plus albumin when available, or with norepinephrine in the ICU, or with midodrine + octreotide as alternatives (Wong et al., 2022). We correct triggers like infection, GI bleeding, over-diuresis, excessive lactulose causing hypovolemia, and large-volume paracentesis without albumin.

Chiropractic care helps with venous return through movement and breathing strategies, safe postural transitions, and minimizing orthostatic stress that can worsen renal hypoperfusion.

Ascites: SAAG, Diuretics, and Albumin Replacement

We calculate the serum-ascites albumin gradient (SAAG) to confirm portal-hypertensive ascites and send cytology when indicated (Runyon, 2004). Treatment includes sodium restriction (≈2 g/day), diuretic pairs such as spironolactone 100 mg + furosemide 40 mg (lower doses for smaller patients), and albumin replacement following large-volume paracentesis to prevent circulatory dysfunction and HRS (Bernardi et al., 2012).

Chiropractic contributions include core stabilization, postural support, and gentle manual therapy to reduce pain associated with distension and altered gait.

Hepatic Encephalopathy: Clinical Diagnosis, Lactulose Parameters, and Rifaximin

We diagnose hepatic encephalopathy (HE) clinically; ammonia levels are not reliable screening tools because of variability in specimen handling (Vilstrup et al., 2014). We titrate lactulose to 2–3 soft stools/day, with clear hold parameters to prevent dehydration and hypokalemia, and add rifaximin to prevent recurrence (Bass et al., 2010). We evaluate for precipitating factors: infection, GI bleeding, hypokalemia, or excessive lactulose. We counsel patients to avoid driving and follow local DMV assessment processes while cognition is impaired.

Variceal Bleeding: Antibiotics, EGD, Banding, and Beta Blockers

We initiate antibiotic prophylaxis, perform EGD within 12 hours, band the varices until eradication, and start a nonselective beta-blocker. I prefer carvedilol because it combines nonselective beta-blockade (reduces portal inflow) with alpha-1 blockade (reduces intrahepatic resistance), yielding greater reductions in hepatic venous pressure gradient (HVPG) and survival advantages compared to selective agents (Tripathi et al., 2010; Reiberger et al., 2013). We transition patients from metoprolol to carvedilol in collaboration with cardiology.

TIPS Considerations: Timing and MELD-Based Judgment

We consider transjugular intrahepatic portosystemic shunt (TIPS) early for recurrent bleeding despite endoscopic therapy and beta blockers, or when beta blockers are not tolerated. MELD <18 is generally favorable; higher MELD increases periprocedural risk and post-TIPS hepatic insufficiency (Garcia-Tsao et al., 2017). TIPS reduces portal pressure and ascites but raises encephalopathy risk by shunting blood past hepatic detoxification.

Rebalanced Hemostasis in Cirrhosis: Restrictive Transfusion and Product Stewardship

An elevated INR in cirrhosis reflects synthetic dysfunction, not bleeding risk. Correcting INR with FFP in the absence of bleeding does not improve outcomes and increases the risk of volume overload (Northup et al., 2008). We use platelets for severe thrombocytopenia with active bleeding and cryoprecipitate for low fibrinogen. We follow restrictive transfusion protocols because over-transfusion can raise portal pressure and precipitate hemorrhage (Villanueva et al., 2013).

Elevated Liver Enzymes: R-Factor Pattern Recognition and Function Versus Injury

We classify injury with the R-factor (ALT and ALP relative to upper limits) into hepatocellular, cholestatic, or mixed patterns, guiding targeted workups (Chalasani et al., 2014). Extremely high enzymes (in the thousands) suggest ischemia, acetaminophen toxicity, or severe drug-induced liver injury. We differentiate function (INR, bilirubin) from injury markers (AST, ALT, ALP, GGT) to assess true hepatic capacity and prognosis.

We reserve liver biopsy for equivocal cases or suspected autoimmune hepatitis with high titers (EASL, 2015), balancing diagnostic clarity against bleeding risk in decompensated patients.

Portal Vein Thrombosis: Imaging, Anticoagulation, and Safety

We do not screen asymptomatic compensated cirrhotics for portal vein thrombosis (PVT), but we evaluate new decompensation with Doppler ultrasound followed by cross-sectional imaging. We anticoagulate when there are signs of intestinal ischemia and avoid anticoagulating chronic, completely occlusive PVT with cavernous transformation. We follow the Baveno VII guidance for variceal screening and consider a nonselective beta-blocker before or alongside anticoagulation (De Franchis et al., 2022).

Functional Medicine Layers: Nutrition, Microbiome, and Metabolic Support

We integrate functional medicine to enhance recovery:

• Protein optimization: Adequate protein prevents sarcopenia and reduces ammonia from catabolism.
• Microbiome modulation: Dietary fiber, prebiotics, and lactulose synergize to reduce ammonia absorption and strengthen the gut barrier.
• Micronutrients: Zinc and branched-chain amino acids can improve ammonia detoxification pathways in select patients.
• Alcohol cessation and toxin avoidance: Structured counseling and medical therapy where indicated.
• Sleep and circadian alignment: Non-pharmacologic strategies improve cognitive resilience during encephalopathy.

Dr. Cardenas supervises all plans for compatibility with pharmacotherapies and the patient’s medical trajectory.

Personal Injury Care and Rehabilitation: Safe Progressions for Vulnerable Physiology

In personal injury rehabilitation for patients with GI or hepatic fragility, we calibrate exercise intensity to avoid hemodynamic stress:

• Low-impact, graded progressions with walk-rest cycles, flexibility, and light resistance bands.
• Non-hepatotoxic pain strategies and interventional techniques that avoid systemic risks.
• Monitoring orthostatic status and beta-blocker effects, adjusting pacing to prevent syncope and fatigue.
• Coordination with cardiology and hepatology for safe transitions, especially when initiating carvedilol or planning TIPS.

This careful approach enables patients to regain function without provoking complications, aligning medical safety with musculoskeletal recovery.

Practical Takeaways

• Use validated risk scores for GI bleeding; match endoscopic findings to clinical severity.
• Eliminate surreptitious NSAID exposure and identify pill esophagitis causes such as doxycycline.
• Consider lifelong PPI in large hiatal hernias with Cameron ulcers or high-risk anticoagulated patients; eradicate pylori.
• Distinguish between painful and painless lower GI bleeding; optimize colonoscopy timing for optimal prep.
• Restart anticoagulation in a monitored setting; use heparin bridge to test stability.
• Treat acute pancreatitis with aggressive LR fluids, multimodal analgesia, and early nutrition; avoid premature pseudocyst drainage.
• Recognize cholangitis early and perform ERCP within 24 hours.
• Diagnose mesenteric ischemia via watershed thickening and clinical context; use anticoagulation or stenting when indicated.
• Manage fecal impaction by location; prioritize digital disimpaction for rectal blockade.
• In IBD flares, cap steroid dosing, use heparin thromboprophylaxis, and optimize biologic strategies.
• Prefer IV iron for intolerant patients; follow restrictive transfusion strategies, especially in cirrhosis.
• In acute liver failure, monitor encephalopathy and use NAC
• In AAH, score severity, screen for infection, use NAC judiciously, and be selective with steroids; consider early transplant evaluation and MAT for AUD.
• For ascites, calculate SAAG, use balanced diuretics, and replace albumin after large-volume paracentesis.
• For HE, set lactulose hold parameters, add rifaximin, and advise no driving until assessed.
• For varices, start antibiotics, perform EGD and banding, and use carvedilol to reduce portal pressure.
• Consider TIPS early in appropriate MELD ranges.
• Respect rebalanced hemostasis; avoid correcting INR with FFP absent bleeding.
• Use R-factor and separate function from injury metrics; biopsy selectively.
• Evaluate PVT with targeted imaging and anticoagulate when warranted; follow Baveno guidance.
• Integrate chiropractic and functional medicine to optimize autonomic tone, mechanics, and recovery.

References

• ACG Clinical Guideline: Treatment of Patients With Acute Upper Gastrointestinal Bleeding (Laine, L., Barkun, A. N., Saltzman, J. R., Martel, M., & Leontiadis, G. I., 2021). The American Journal of Gastroenterology, 116(5), 899–917. https://doi.org/10.14309/ajg.0000000000001242
• Urgent vs. next-day colonoscopy for acute lower gastrointestinal bleeding: a randomized controlled trial (Oakland, K., Kothiwale, S., Forehand, T., et al., 2020). The New England Journal of Medicine, 382, 524–533.
• ACG Clinical Guideline: Management of Patients With Acute Lower Gastrointestinal Bleeding (Strate, L. L., & Gralnek, I. M., 2016). The American Journal of Gastroenterology, 111(4), 459–474. https://doi.org/10.1038/ajg.2016.41
• The overall management of acute upper gastrointestinal bleeding (Jairath, V., & Barkun, A. N., 2014). Gastrointestinal Endoscopy, 80(1), 1–10.
• Acute pancreatitis (Lankisch, P. G., Apte, M., & Banks, P. A., 2015). The Lancet, 386(9988), 85–96.
• Diagnosis and management of acute cholangitis (Lee, J. G., 2021). UpToDate.
• Acute mesenteric ischemia: guidelines of the World Society of Emergency Surgery (Bala, M., Kashuk, J., Moore, E. E., et al., 2017). World Journal of Emergency Surgery, 12(1), 38.
• Fecal impaction: a review (Obokhare, I., 2012). Journal of the National Medical Association, 104(5-6), 251–254.
• The evaluation and management of dysphagia (Khan, A., & Vaezi, M. F., 2012). Gastroenterology & Hepatology, 8(7), 462–465.
• Clinical practice guidelines from the AABB: Red blood cell transfusion thresholds and storage (Carson, J. L., Guyatt, G., Heddle, N. M., et al., 2016). JAMA, 316(19), 2025–2035.
• Acute liver failure (Bernal, W., & Wendon, J., 2010). The Lancet.
• AASLD position paper: Acute liver failure (Polson, J., & Lee, W. M., 2005). Hepatology.
• MELD 3.0: Development and validation (Kim, D. et al., 2021). Hepatology.
• Glasgow alcoholic hepatitis score (Forrest, E., Mellor, J., et al., 2005). Gut.
• Management of alcoholic hepatitis (Mathurin, P., & Lucey, M. R., 2012). The New England Journal of Medicine.
• Phosphatidylethanol as an alcohol biomarker (Stewart, S. H., et al., 2014). Alcoholism: Clinical and Experimental Research.
• Early liver transplantation for severe alcoholic hepatitis (Im, G. Y., Cameron, A. M., et al., 2019). The New England Journal of Medicine.
• The American Psychiatric Association practice guideline for alcohol use disorder (Reus, V. I., et al., 2018). APA.
• Albumin infusion in patients undergoing large-volume paracentesis (Bernardi, M., Caraceni, P., et al., 2012). Hepatology.
• EASL Clinical Practice Guidelines: Management of patients with decompensated cirrhosis (EASL, 2018). Journal of Hepatology.
• Hepatopulmonary syndrome and portopulmonary hypertension (Krowka, M. J., Fallon, M. B., et al., 2018). Clinical Liver Disease.
• AASLD guidance for hepatorenal syndrome–AKI (Wong, F. et al., 2022). Hepatology Communications.
• Management of adult patients with ascites due to cirrhosis (Runyon, B. A., 2004). Hepatology.
• Hepatic encephalopathy in chronic liver disease: Practice guideline (Vilstrup, H., Amodio, P., et al., 2014). Hepatology.
• Rifaximin treatment in hepatic encephalopathy: Randomized trial (Bass, N. M., et al., 2010). The New England Journal of Medicine.
• Baveno VII consensus on portal hypertension (De Franchis, R., t al., 2022). Journal of Hepatology.
• Carvedilol vs. propranolol in portal hypertension (Tripathi, D. et al., 2010). Gut.
• Beta-blockers and portal pressure reduction (Reiberger, T. et al., 2013). Hepatology.
• Restrictive transfusion strategy in GI bleeding (Villanueva, C. et al., 2013). The New England Journal of Medicine.
• Coagulation abnormalities in cirrhosis: Rebalanced hemostasis (Northup, P. G., et al., 2008). Hepatology.
• AASLD DILI guidance: Pattern recognition and management (Chalasani, N. et al., 2014). Clinical Liver Disease.
• TIPS in portal hypertension: Patient selection and outcomes (Garcia-Tsao, G. et al., 2017). Gastroenterology.
• EASL Clinical Practice Guidelines: Autoimmune hepatitis (EASL, 2015). Journal of Hepatology.
• Fecal microbiota transplantation for Clostridioides difficile infection (Mishra, R., & Khanna, S., 2021). Current Opinion in Gastroenterology.
• Review article: The risks and benefits of suspending IBD therapy (Siegel, C. A., 2023). Alimentary Pharmacology & Therapeutics.

SEO tags: integrative gastroenterology, integrative hepatology, GI bleeding management, peptic ulcer disease, NSAID gastrointestinal risk, pill esophagitis doxycycline, proton pump inhibitor strategy, H. pylori eradication, lower GI bleeding colonoscopy timing, anticoagulation GI bleed heparin bridge, hiatal hernia Cameron ulcers, acute pancreatitis fluids multimodal pain, cholangitis ERCP urgency, mesenteric ischemia watershed, fecal impaction digital disimpaction, dysphagia oropharyngeal esophageal, Clostridioides difficile fidaxomicin microbiota therapy, IBD flare thromboprophylaxis biologics, iron deficiency anemia IV iron, restrictive transfusion strategy cirrhosis, acute liver failure N-acetylcysteine, alcohol-associated hepatitis MELD NAC steroids, cirrhosis ascites SAAG albumin, hepatic encephalopathy lactulose rifaximin, variceal bleeding carvedilol banding, TIPS MELD selection, rebalanced hemostasis INR FFP, R-factor liver injury pattern, portal vein thrombosis anticoagulation, functional medicine gut-liver axis, chiropractic autonomic modulation, rehabilitation low-impact graded activity, Injury Medical Clinic PA, Mission Plaza Injury Medical Clinic, Dr. Maria Guadalupe Cardenas MD, Dr. Alex Jimenez DC APRN, pushasrx.com, LinkedIn dralexjimenez